revenu increas yoy net profit grew
yoy strong growth due low base revenu
growth line expect net profit miss
net margin improv pp yoy declin pp qoq
net profit margin
revis china price recent due aggress
price strategi mnc adjust peak sale
estim china bn
bn reduc hengrui market share estim
trim tp base dcf model
impli price-to-earnings maintain outperform compani
go deliv solid growth compound-annual-growth-rate next year
quit new drug includ prioriti review list
compani announc result revenu increas
yoy net profit grew yoy strong growth due
low base revenu net profit deliv
growth yoy revenu in-lin expect net
profit miss yoy forecast slightli
gross margin stabl yoy declin slightli pp qoq net
margin declin pp compar net profit margin
 expens surg yoy reach
mn sell market expens sale increas
pp larger expens drove net profit compar
net cash oper declin slightli mn
mn due higher oper cash outflow receiv sell
product provid servic first nine month increas
lag revenu growth
recent saw polici headwind china innov mnc
adopt aggress strategi china cut drug price
gain volum oncolog drug among mnc
lower price averag includ ndrl nation
estimate pot chg tp
number share mn
chg prev ep
opdivo bmss keytrud merck pd- set price
china much cheaper initi expect august set
price round discount price us estim
mnc set price china match oversea price
consist histor price strategi
figur price opdivo keytruda china
revis china market size forecast impact
decreas price could off-set volum adjust
peak sale estim china
bn bn meanwhil reduc hengrui market
share forecast see domest compani price
per year depend indic
besid compani late stage pipelin target
list hong kong near term valuat innov around
bn actual drive market valuat
besid list compani provid investor
choic want exposur china market
trim tp maintain
trim net profit forecast
compani peak sale forecast long term
compani face aggress challeng mnc maintain
outperform compani go deliv solid growth
compound-annual-growth-rate next three year new tp base dcf
statu non-u analyst us disclosur credit suiss seek busi compani cover research report result investor
awar firm may conflict interest could affect object report investor consid report singl factor make invest
charl martineau univers toronto compani mention price
serena shao katherin fu certifi respect compani secur individu analyz view express
report accur reflect person view subject compani secur part
compens directli indirectli relat specif recommend view express report
price rate histori jiangsu hengrui medicin co ltd
signifi initi assumpt coverag
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst
coverag univers consist compani cover analyst within relev sector outperform repres
attract neutral less attract underperform least attract invest opportun octob
canadian well european rate base stock total return rel analyst coverag univers consist
compani cover analyst within relev sector outperform repres attract neutral less attract
underperform least attract invest opportun latin american asia stock exclud japan australia rate
base stock total return rel averag total return relev countri region benchmark india bse sensex index
prior octob canadian rate base stock absolut total return potenti current share price
rel attract stock total return potenti within analyst coverag univers australian new zealand stock
expect total return calcul includ roll dividend yield outperform rate assign greater
equal under-perform less equal neutral may assign
overlap rate rang allow analyst assign rate put context associ risk prior may
rang outperform under-perform rate overlap neutral threshold oper
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
circumst
rate nr credit suiss equiti research invest rate view stock secur relat
compani time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate
invest view equiti secur compani relat product
volatil indic stock defin volatil stock price move month least
past month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or
valuat sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector
credit suiss distribut stock rate bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform
